Pages

Tuesday, August 27, 2013

Health Care Reform Articles - August 27, 2013


How to Charge $546 for Six Liters of Saltwater



It is one of the most common components of emergency medicine: an intravenous bag of sterile saltwater.
Luckily for anyone who has ever needed an IV bag to replenish lost fluids or to receive medication, it is also one of the least expensive. The average manufacturer’s price, according to government data, has fluctuated in recent years from 44 cents to $1.
Yet there is nothing either cheap or simple about its ultimate cost, as I learned when I tried to trace the commercial path of IV bags from the factory to the veins of more than 100 patients struck by a May 2012 outbreak of food poisoning in upstate New York.
Some of the patients’ bills would later include markups of 100 to 200 times the manufacturer’s price, not counting separate charges for “IV administration.” And on other bills, a bundled charge for “IV therapy” was almost 1,000 times the official cost of the solution.
It is no secret that medical care in the United States is overpriced. But as the tale of the humble IV bag shows all too clearly, it is secrecy that helps keep prices high: hidden in the underbrush of transactions among multiple buyers and sellers, and in the hieroglyphics of hospital bills.
At every step from manufacturer to patient, there are confidential deals among the major players, including drug companies, purchasing organizations and distributors, and insurers. These deals so obscure prices and profits that even participants cannot say what the simplest component of care actually costs, let alone what it should cost.
And that leaves taxpayers and patients alike with an inflated bottom line and little or no way to challenge it.
A Price in Flux
In the food-poisoning case, some of the stricken were affluent, and others barely made ends meet. Some had private insurance; some were covered by government programs like Medicare and Medicaid; and some were uninsured.
In the end, those factors strongly (and sometimes perversely) affected overall charges for treatment, including how much patients were expected to pay out of pocket. But at the beginning, there was the cost of an IV bag of normal saline, one of more than a billion units used in the United States each year.
“People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning,” said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States.
It was a rare unguarded comment. Ms. Spak — like a spokesman for Hospira, another giant in the field — later insisted that all information about saline solution prices was private.
In fact, manufacturers are required to report such prices annually to the federal government, which bases Medicare payments on the average national price plus 6 percent. The limit for one liter of normal saline (a little more than a quart) went to $1.07 this year from 46 cents in 2010, an increase manufacturers linked to the cost of raw materials, fuel and transportation. That would seem to make it the rare medical item that is cheaper in the United States than in France, where the price at a typical hospital in Paris last year was 3.62 euros, or $4.73.

Obamacare endangers Obamacare

By Jennifer Rubin, Updated: 

The best thing opponents of Obamacare have going for them is Obamacare. The implementation glitches and the ensuing delays have created a perverse system: Individuals must purchase insurance with no out-of-pocket cost cap while employers are under no obligation to provide insurance. Aside from the gross unfairness and the difficulty in rolling out the plans (e.g. exchanges aren’t set up, there is no guarantee personal information will be protected, the centrality of a corrupted IRS) Obamacare’s debut is bringing home several unpleasant realities.
 In January, a study by Kurt Giesa and Chris Carlson in the magazine of the American Academy of Actuaries estimated that 80 percent of Americans below the age of 30 in the individual market would find themselves with higher premiums next year than this year, even after subsidies. Early data from the states suggest this estimate may not be far off the mark. . . .The young and healthy are expected to enable that system to function in two ways: They will pay significantly higher rates than they do now, and more of them will buy coverage. But there is an obvious contradiction between these two expectations. If the cost of something goes up, why would more people buy it?
Obamacare’s promise of universal, affordable health-care insurance is illusory; it will be neither universal nor affordable.
Second, young and healthy voters will be getting a raw deal and they know it. If they behave rationally and take up Supreme Court Chief Justice John Roberts offer — don’t insure and just pay the tax — the system will collapse. The pool of covered people in the exchanges will be older (although Medicare remains in place for those 65 years and over) and sicker, the costs will increase, and the alternative will be to squeeze care (i.e. ration) or hugely increase taxes. Levin sums up: “Its mistreatment of the young and healthy is therefore actually a huge problem for the law, and points to the core of the new system’s economic irrationality, or rather to its failure to contend with how people understand their economic options.”
The other adverse consequences (stifling medical device companies, over-pricing the cost of labor, increases in part-time work) will also be felt as Obamacare works its will on the economy by taxes, mandates and more taxes.
It is a misnomer then to call the problems ones of “implementation.” Even if states get their exchanges up and even if the government prevails in laws challenging the obligations of religious-based employers and even if the exchanges manage to secure personal data, the underlying assumptions on which Obamacare rests — young and healthy people can be corralled into the system to subsidize old and sick people is illogical. If you are under 26 years old then you likely stay on your parents’ plan. If you’re over 26 and are making little income you probably qualify for expanded Medicaid insurance. And if you are over 26 and have an income but no employer-based coverage you probably pay the fine and sign up for subsidized care when and if you get very ill or seriously injured. Besides all that, you’d still have the impact on hiring and the part-time work boom.

Health law coverage can be tough sell in some states

Group’s experience in Texas underscores resistance, uncertainty

No comments:

Post a Comment